Evidence map›Paper›PMID 26239995›Full record

ArticleAntimicrobial agents and chemotherapy2015

In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.

Anuradha Chowdhary, Ferry Hagen, Ilse Curfs-Breuker, Hugo Madrid, G Sybren de Hoog, Jacques F Meis

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anuradha ChowdharyDepartment of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.ORCID http://orcid.org/0000-0002-2028-7462
Ferry HagenDepartment of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-5622-1916
Ilse Curfs-BreukerDepartment of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Hugo MadridCenter for Genomics and Bioinformatics and Medicine Faculty, Mayor University, Santiago, Chile.
G Sybren de HoogCBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands.
Jacques F MeisDepartment of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands Department of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands j.meis@cwz.nl.ORCID http://orcid.org/0000-0003-3253-6080

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The in vitro susceptibilities of 24 worldwide Exserohilum isolates belonging to 10 species from human and environmental sources were determined for eight antifungal drugs. The strains were characterized by internal transcribed spacer (ITS) sequencing and amplified fragment length polymorphism fingerprinting. Posaconazole had the lowest geometric mean MIC (0.16 μg/ml), followed by micafungin (0.21 μg/ml), amphotericin B (0.24 μg/ml), itraconazole (0.33 μg/ml), voriconazole (0.8 μg/ml), caspofungin (1.05 μg/ml), isavuconazole (1.38 μg/ml), and fluconazole (15.6 μg/ml).

Indexed as

Amphotericin BAmplified Fragment Length Polymorphism AnalysisAntifungal AgentsAscomycotaCaspofunginEchinocandinsFluconazoleGenotypeItraconazoleLipopeptidesMicafunginMicrobial Sensitivity TestsMolecular Sequence DataNitrilesPyridinesTriazolesAmphotericin BAntifungal AgentsCaspofunginEchinocandinsFluconazoleisavuconazoleItraconazoleLipopeptidesMicafunginNitrilesposaconazolePyridinesTriazolesVoriconazole

Identifiers

PMID26239995
PMCPMC4576068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.